Sue - Interview 47  

Sue - Interview 47

Age at Interview: 68
Sex: Female
Age at Diagnosis: 66
Background: Sue is married and she has two grown-up children. She is a retired secretary. Ethnic background/nationality: White British.

Brief outline:Sue was diagnosed with lung cancer in 2008. She had 4 cycles of chemotherapy, which was effective, but had bad side effects. When the tumour grew again in 2009 she started a biological therapy, erlotinib (Tarceva) with good results, and is still having it.

More about me...

To watch or read an interview clip, click on the heading that interests you. Either a video,audio recording or text will open, depending on the clip
To read what was said without video or audio, click here
To print the interview’s text, click here
Female
When Sue breathed out it sounded almost like an instrument starting up.
 
Sue was told that she could either have more chemotherapy or start the biological therapy erlotinib (Tarceva).
 
Soon after starting erlotinib (Tarceva) Sue had various side effects, including a skin rash.
 
Other side effects that Sue experienced included frizzy hair, poor nails, dry skin, sore itchy eyes and occasional diarrheoa. She found many products to relieve symptoms.
 
Sue is glad that she decided to have one of the biological therapies. She has been taking erlotinib (Tarceva) for over a year and it is still working well.
 
Sue has been well supported by her husband, family and friends. Erlotinb makes her tired but she still enjoys walks, holidays and outings.
 
Sue is aware that her treatment may cost the NHS a great deal of money because she will be taking it for as long as it is effective.
Karol Sikora - Lung cancer
   Support our work

Mail to a friend

Send